BC
AGN

Bartlett & Co’s Allergan plc AGN Stock Holding History

Bartlett & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-94
Closed -$16K – 950
2019
Q2 		$16K Buy
+94
New +$13K ﹤0.01% 555
2019
Q1 		– Sell
-21
Closed -$3K – 755
2018
Q4 		$3K Hold
21
– – ﹤0.01% 648
2018
Q3 		$4K Hold
21
– – ﹤0.01% 652
2018
Q2 		$4K Hold
21
– – ﹤0.01% 654
2018
Q1 		$4K Hold
21
– – ﹤0.01% 672
2017
Q4 		$3K Hold
21
– – ﹤0.01% 660
2017
Q3 		$4K Buy
+21
New +$4.88K ﹤0.01% 634
2015
Q2 		– Sell
-256
Closed -$76K – 766
2015
Q1 		$76K Buy
+256
New +$73K ﹤0.01% 361

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bartlett & Co's AGN Position: Q3 2019 in Review

Bartlett & Co sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 94 shares — an estimated $16K sold.

Bartlett & Co first reported a position in AGN in Q1 2015 and held it in 8 quarters. The position peaked at $76K in Q1 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Bartlett & Co reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Bartlett & Co sold 94 Allergan plc shares in Q3 2019, an estimated $16K.
  • Bartlett & Co first reported a position in Allergan plc in Q1 2015 and held it in 8 quarters.
  • Bartlett & Co's Allergan plc position peaked at $76K in Q1 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Bartlett & Co's 13F filing for Q3 2019, filed 4 Nov 2019.